Ginkgo Bioworks
DNA
DNA
342 hedge funds and large institutions have $1.51B invested in Ginkgo Bioworks in 2024 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 110 increasing their positions, 93 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
32% less capital invested
Capital invested by funds: $2.22B → $1.51B (-$713M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
38% less call options, than puts
Call options by funds: $2.68M | Put options by funds: $4.3M
Holders
342
Holding in Top 10
2
Calls
$2.68M
Puts
$4.3M
Top Buyers
| 1 | +$31.1M | |
| 2 | +$12.8M | |
| 3 | +$5.62M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$3.88M |
| 5 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
+$3.73M |
Top Sellers
| 1 | -$63.2M | |
| 2 | -$11.6M | |
| 3 | -$8.96M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$4.26M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$3.07M |